These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
417 related articles for article (PubMed ID: 9815978)
1. Posttranscriptional regulation of the c-myb proto-oncogene in estrogen receptor-positive breast cancer cells. Gudas JM; Klein RC; Oka M; Cowan KH Clin Cancer Res; 1995 Feb; 1(2):235-43. PubMed ID: 9815978 [TBL] [Abstract][Full Text] [Related]
2. 17 beta-estradiol-regulated expression of protein tyrosine phosphatase gamma gene in cultured human normal breast and breast cancer cells. Zheng J; Kulp SK; Zhang Y; Sugimoto Y; Dayton MA; Govindan MV; Brueggemeier RW; Lin YC Anticancer Res; 2000; 20(1A):11-9. PubMed ID: 10769629 [TBL] [Abstract][Full Text] [Related]
3. Inactivation of a c-Myb/estrogen receptor fusion protein in transformed primary cells leads to granulocyte/macrophage differentiation and down regulation of c-kit but not c-myc or cdc2. Hogg A; Schirm S; Nakagoshi H; Bartley P; Ishii S; Bishop JM; Gonda TJ Oncogene; 1997 Dec; 15(24):2885-98. PubMed ID: 9416832 [TBL] [Abstract][Full Text] [Related]
4. Nitric oxide-releasing agents and cGMP analogues inhibit murine erythroleukemia cell differentiation and suppress erythroid-specific gene expression: correlation with decreased DNA binding of NF-E2 and altered c-myb mRNA expression. Suhasini M; Boss GR; Pascual FE; Pilz RB Cell Growth Differ; 1995 Dec; 6(12):1559-66. PubMed ID: 9019161 [TBL] [Abstract][Full Text] [Related]
5. [The expression of c-myb is strongly associated with the presence of estrogen and progesterone receptors in breast cancer]. Guerin M; Barrois M; Riou G C R Acad Sci III; 1988; 307(20):855-61. PubMed ID: 2907731 [TBL] [Abstract][Full Text] [Related]
6. Transcriptional repression of the neu protooncogene by estrogen stimulated estrogen receptor. Russell KS; Hung MC Cancer Res; 1992 Dec; 52(23):6624-9. PubMed ID: 1358436 [TBL] [Abstract][Full Text] [Related]
7. Expression of estrogen receptors in estrogen receptor-negative human breast carcinoma cells: modulation of epidermal growth factor-receptor (EGF-R) and transforming growth factor alpha (TGF alpha) gene expression. Sheikh MS; Shao ZM; Chen JC; Li XS; Hussain A; Fontana JA J Cell Biochem; 1994 Mar; 54(3):289-98. PubMed ID: 8200909 [TBL] [Abstract][Full Text] [Related]
8. Transcriptional regulation of vascular endothelial growth factor by estradiol and tamoxifen in breast cancer cells: a complex interplay between estrogen receptors alpha and beta. Buteau-Lozano H; Ancelin M; Lardeux B; Milanini J; Perrot-Applanat M Cancer Res; 2002 Sep; 62(17):4977-84. PubMed ID: 12208749 [TBL] [Abstract][Full Text] [Related]
9. Altered gene expression in drug-resistant human breast cancer cells. Wosikowski K; Schuurhuis D; Kops GJ; Saceda M; Bates SE Clin Cancer Res; 1997 Dec; 3(12 Pt 1):2405-14. PubMed ID: 9815641 [TBL] [Abstract][Full Text] [Related]
10. Stimulation of c-myc oncogene expression associated with estrogen-induced proliferation of human breast cancer cells. Dubik D; Dembinski TC; Shiu RP Cancer Res; 1987 Dec; 47(24 Pt 1):6517-21. PubMed ID: 3677090 [TBL] [Abstract][Full Text] [Related]
11. Emergence of MCF-7 cells overexpressing a transfected epidermal growth factor receptor (EGFR) under estrogen-depleted conditions: evidence for a role of EGFR in breast cancer growth and progression. Miller DL; el-Ashry D; Cheville AL; Liu Y; McLeskey SW; Kern FG Cell Growth Differ; 1994 Dec; 5(12):1263-74. PubMed ID: 7696175 [TBL] [Abstract][Full Text] [Related]
12. Retinoic acid induces expression of the interleukin-1beta gene in cultured normal human mammary epithelial cells and in human breast carcinoma lines. Liu L; Gudas LJ J Cell Physiol; 2002 Nov; 193(2):244-52. PubMed ID: 12385002 [TBL] [Abstract][Full Text] [Related]
13. Estradiol induction of retinoic acid receptors in human breast cancer cells. Roman SD; Ormandy CJ; Manning DL; Blamey RW; Nicholson RI; Sutherland RL; Clarke CL Cancer Res; 1993 Dec; 53(24):5940-5. PubMed ID: 8261407 [TBL] [Abstract][Full Text] [Related]
14. Induction of aromatase (CYP19) expression in breast cancer cells through a nongenomic action of estrogen receptor alpha. Kinoshita Y; Chen S Cancer Res; 2003 Jul; 63(13):3546-55. PubMed ID: 12839940 [TBL] [Abstract][Full Text] [Related]
15. Expression levels of estrogen receptor-alpha, estrogen receptor-beta, coactivators, and corepressors in breast cancer. Kurebayashi J; Otsuki T; Kunisue H; Tanaka K; Yamamoto S; Sonoo H Clin Cancer Res; 2000 Feb; 6(2):512-8. PubMed ID: 10690532 [TBL] [Abstract][Full Text] [Related]
17. 1alpha,25-Dihydroxyvitamin D3 down-regulates estrogen receptor abundance and suppresses estrogen actions in MCF-7 human breast cancer cells. Swami S; Krishnan AV; Feldman D Clin Cancer Res; 2000 Aug; 6(8):3371-9. PubMed ID: 10955825 [TBL] [Abstract][Full Text] [Related]
18. Antisense estrogen receptor RNA expression increases epidermal growth factor receptor gene expression in breast cancer cells. deFazio A; Chiew YE; McEvoy M; Watts CK; Sutherland RL Cell Growth Differ; 1997 Aug; 8(8):903-11. PubMed ID: 9269899 [TBL] [Abstract][Full Text] [Related]
19. Role of posttranscriptional processes in the regulation of glutathione S-transferase P1 gene expression in human breast cancer cells. Jhaveri MS; Stephens TE; Morrow CS Biochem Biophys Res Commun; 1997 Aug; 237(3):729-34. PubMed ID: 9299435 [TBL] [Abstract][Full Text] [Related]
20. Estrogen receptor alpha and beta subtype expression and transactivation capacity are differentially affected by receptor-, hsp90- and immunophilin-ligands in human breast cancer cells. Gougelet A; Bouclier C; Marsaud V; Maillard S; Mueller SO; Korach KS; Renoir JM J Steroid Biochem Mol Biol; 2005 Feb; 94(1-3):71-81. PubMed ID: 15862952 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]